Carisma Therapeutics Inc <CARM.OQ> expected to post a loss of 10 cents a share - Earnings Preview

• Carisma Therapeutics Inc CARM.OQ CARM.O is expected to show a rise in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

• The Philadelphia Pennsylvania-based company is expected to report a 9.7% increase in revenue to $3.725 million from $3.4 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Carisma Therapeutics Inc is for a loss of 10 cents per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Carisma Therapeutics Inc is $1.00​, above​ its last closing price of $0.25. ​​​

This summary was machine generated May 5 at 14:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)